Not applicableUnknownNCT05993897What this trial is testingEffect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrial RemodelingWho this might be right forAtrial Fibrillation Aswan University 60
Post-approval studies (Phase 4)WithdrawnNCT04531397What this trial is testingEfficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney DiseaseWho this might be right forProteinuriaChronic Kidney Diseases Children's Hospital of Fudan University
Post-approval studies (Phase 4)Study completedNCT03977116What this trial is testingSodium-glucose Co-transporter 2 Inhibitors Effects in Failing Heart PatientsWho this might be right forDiabetes MellitusHeart FailureVentricular Arrythmia University of Campania Luigi Vanvitelli 100
Post-approval studies (Phase 4)Ended earlyNCT05346653What this trial is testingThe Hemodynamic Effects of SGLT2i in Acute Decompensated Heart FailureWho this might be right forAcute Decompensated Heart Failure University of Chicago 1
Not applicableStudy completedNCT07302464What this trial is testingSodium Glucose Co-Transporter 2 Inhibitors on Estimated Glomerular Filtration Rate in Diabetic Versus Non-Diabetic Chronic Kidney Disease PatientsWho this might be right forSodium Glucose Co-Transporter 2 InhibitorsEstimated Glomerular Filtration RateDiabetes+1 more Ain Shams University 60
Post-approval studies (Phase 4)Study completedNCT03226457What this trial is testingSGLT2 Inhibition in Combination With Diuretics in Heart FailureWho this might be right forHeart FailureType 2 Diabetes Mellitus University of Dundee 23
Very early researchStudy completedNCT06812429What this trial is testingEffects of Sodium-Glucose Co-transporter 2 Inhibitors on InflammationWho this might be right forInflammation Washington University School of Medicine 6
Large-scale testing (Phase 3)Study completedNCT07344922What this trial is testingSGLT2 Inhibitors in Non-Diabetic CKD: Effects on Vascular Calcification and AnemiaWho this might be right forChronic Kidney DiseaseAnemiaCardiovascular Calcification Mansoura University 100
Testing effectiveness (Phase 2)UnknownNCT06113900What this trial is testingAssessment of Safety and Efficacy of SGLT2is Among LN PatientsWho this might be right forLupus Nephritis Ain Shams University 50
Not applicableUnknownNCT03917758What this trial is testingAntidiuretic Function Before and During Treatment With SGLT2 InhibitorsWho this might be right forDiabetes Mellitus, Type 2Arterial HypertensionBody Weight Changes University of Turin, Italy 30
Post-approval studies (Phase 4)UnknownNCT03573102What this trial is testingEffect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic PatientsWho this might be right forDiabetic Nephropathies Nahla H Tohami 60
Testing effectiveness (Phase 2)Study completedNCT05570305What this trial is testingZibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated AlbuminuriaWho this might be right forChronic Kidney Diseases University Medical Center Groningen 42
Very early researchLooking for participantsNCT06430684What this trial is testingFeasibility Trial of Sodium-GLucose CoTransporter 2 INhibitors in Pediatric Chronic KIDney DiSeaseWho this might be right forChronic Kidney DiseasesPediatric Kidney Disease Ann & Robert H Lurie Children's Hospital of Chicago 40
Post-approval studies (Phase 4)Study completedNCT05735197What this trial is testingEffect of Dapagliflozin on Renal Outcomes and Bone Mineral Disease in Non-diabetic Chronic Kidney Disease PatientsWho this might be right forChronic Kidney DiseasesBone Diseases, Metabolic Mansoura University 100
Large-scale testing (Phase 3)Study completedNCT04304261What this trial is testingEffects of SGLT2i on the Cognitive Function in T2DM Patient (ESCDP)Who this might be right forDiabetes Mellitus, Type 2Cognitive Functions Confusion Third Military Medical University 100
Not applicableStudy completedNCT03741972What this trial is testingMetabolic and Hemodynamic Effects of the Inhibitors of Type 2 Sodium Glucose Co-transporters (ISGLT2) in Diabetic Patients With Heart FailureWho this might be right forHeart Failure Germans Trias i Pujol Hospital 100
Post-approval studies (Phase 4)Study completedNCT03959501What this trial is testingMetabolic Responses of Dapagliflozin vs Sitagliptin in T2DM Patients Inadequately Controlled With Insulin TherapyWho this might be right forType 2 DiabetesKetonemia The University of Hong Kong 60
Post-approval studies (Phase 4)Not Yet RecruitingNCT07405216What this trial is testingEfficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney DiseaseWho this might be right forChronic Kidney Disease (Mild to Moderate)AlbuminuriaAdolescent+1 more Centenario Hospital Miguel Hidalgo 200
Large-scale testing (Phase 3)UnknownNCT05373004What this trial is testingComparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney DiseaseWho this might be right forDiabetic Nephropathy Type 2 Omar Tarek Elfarargi 212
Post-approval studies (Phase 4)Looking for participantsNCT06249945What this trial is testingEMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal DiseaseWho this might be right forHeart Failure With Preserved Ejection FractionEnd Stage Renal Disease on Dialysis National Taiwan University Hospital 150